Ana Lucrecia Woodward

Array ( [id] => 7427311 [patent_doc_number] => 20040229874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => '5HT7 Antagonists and inverse agonists' [patent_app_type] => new [patent_app_number] => 10/766741 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20880 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229874.pdf [firstpage_image] =>[orig_patent_app_number] => 10766741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098530 [patent_doc_number] => 20050130989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'N-arylheteroaromatic products compositions containing them and use thereof' [patent_app_type] => utility [patent_app_number] => 10/764653 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43165 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130989.pdf [firstpage_image] =>[orig_patent_app_number] => 10764653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 544953 [patent_doc_number] => 07163944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Cyclic diamine compound and pharmaceutical containing the same' [patent_app_type] => utility [patent_app_number] => 10/763241 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5613 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163944.pdf [firstpage_image] =>[orig_patent_app_number] => 10763241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288221 [patent_doc_number] => 20040147516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Novel pyridazine derivatives and medicines containing the same as effective ingredients' [patent_app_type] => new [patent_app_number] => 10/757525 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38974 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147516.pdf [firstpage_image] =>[orig_patent_app_number] => 10757525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 779396 [patent_doc_number] => 06995264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-07 [patent_title] => 'Process for preparing aripiprazole' [patent_app_type] => utility [patent_app_number] => 10/752490 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2103 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/995/06995264.pdf [firstpage_image] =>[orig_patent_app_number] => 10752490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711261 [patent_doc_number] => 20060052606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Factor xa Inhibitors' [patent_app_type] => utility [patent_app_number] => 10/539372 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14101 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052606.pdf [firstpage_image] =>[orig_patent_app_number] => 10539372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 501087 [patent_doc_number] => 07205303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Substituted heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 10/745224 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16968 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205303.pdf [firstpage_image] =>[orig_patent_app_number] => 10745224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337173 [patent_doc_number] => 20040132742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 10/741558 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3249 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132742.pdf [firstpage_image] =>[orig_patent_app_number] => 10741558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632347 [patent_doc_number] => 20060148817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Pyrazole compounds' [patent_app_type] => utility [patent_app_number] => 10/536899 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16861 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148817.pdf [firstpage_image] =>[orig_patent_app_number] => 10536899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591498 [patent_doc_number] => 20060040950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists' [patent_app_type] => utility [patent_app_number] => 10/540447 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29370 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040950.pdf [firstpage_image] =>[orig_patent_app_number] => 10540447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 260060 [patent_doc_number] => 07572786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-11 [patent_title] => 'Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists' [patent_app_type] => utility [patent_app_number] => 10/540045 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19680 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/572/07572786.pdf [firstpage_image] =>[orig_patent_app_number] => 10540045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 590065 [patent_doc_number] => 07435736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists' [patent_app_type] => utility [patent_app_number] => 10/540304 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14408 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435736.pdf [firstpage_image] =>[orig_patent_app_number] => 10540304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325341 [patent_doc_number] => 20040138203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Bicyclic lactams and sulfonamides with 5-ht1a -affinity and use thereof for preventing and treating cerebral ischaemia' [patent_app_type] => new [patent_app_number] => 10/312813 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5324 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138203.pdf [firstpage_image] =>[orig_patent_app_number] => 10312813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530471 [patent_doc_number] => 07842693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Substituted piperazines' [patent_app_type] => utility [patent_app_number] => 10/732897 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 76048 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842693.pdf [firstpage_image] =>[orig_patent_app_number] => 10732897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474231 [patent_doc_number] => 20040122019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Benzoylguanidine salt and hydrates thereof' [patent_app_type] => new [patent_app_number] => 10/731825 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2130 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122019.pdf [firstpage_image] =>[orig_patent_app_number] => 10731825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325434 [patent_doc_number] => 20040138229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Platelet adenosine diphosphate receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/731815 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23950 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138229.pdf [firstpage_image] =>[orig_patent_app_number] => 10731815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637922 [patent_doc_number] => 07125876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'Substituted heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 10/729499 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20506 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125876.pdf [firstpage_image] =>[orig_patent_app_number] => 10729499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972329 [patent_doc_number] => 06936714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof' [patent_app_type] => utility [patent_app_number] => 10/728580 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10133 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936714.pdf [firstpage_image] =>[orig_patent_app_number] => 10728580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474243 [patent_doc_number] => 20040122021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Enantiomers of 1-[(4-chlorophenyl)phenylmethyl)-4-[(4-methylphenyl)sulfonyl) piperazine' [patent_app_type] => new [patent_app_number] => 10/724640 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10884 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122021.pdf [firstpage_image] =>[orig_patent_app_number] => 10724640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474252 [patent_doc_number] => 20040122023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine' [patent_app_type] => new [patent_app_number] => 10/724611 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10990 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122023.pdf [firstpage_image] =>[orig_patent_app_number] => 10724611 [rel_patent_id] =>[rel_patent_doc_number] =>)